1. Hamyeh, Mohamed, Bernex, Florence, Larive, Romain M, Hendriks, Wiljan J A J, Freiss, Gilles. 2020. PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness. In Theranostics, 10, 1016-1032. doi:10.7150/thno.38537. https://pubmed.ncbi.nlm.nih.gov/31938048/
2. Li, Jing-Ping, Zhang, Xiang-Mei, Liu, Bei-Chen, Zhao, Xiao-Han, Liu, Yun-Jiang. 2023. Comprehensive analysis of the PTPN13 expression and its clinical implication in breast cancer. In Neoplasma, 70, 188-198. doi:10.4149/neo_2023_221117N1110. https://pubmed.ncbi.nlm.nih.gov/36812232/
3. Aptecar, Leticia, Puech, Carole, Lopez-Crapez, Evelyne, D'Hondt, Véronique, Freiss, Gilles. 2023. PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells. In International journal of molecular sciences, 24, . doi:10.3390/ijms242015413. https://pubmed.ncbi.nlm.nih.gov/37895093/
4. Tu, Ruisha, Zhong, Dunjing, Li, Ping, Yu, Shuyong, Song, Jian. 2023. PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer. In Annals of medicine, 55, 2281659. doi:10.1080/07853890.2023.2281659. https://pubmed.ncbi.nlm.nih.gov/38039548/
5. Scrima, Marianna, De Marco, Carmela, De Vita, Fernanda, Malanga, Donatella, Viglietto, Giuseppe. 2012. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer. In The American journal of pathology, 180, 1202-1214. doi:10.1016/j.ajpath.2011.11.038. https://pubmed.ncbi.nlm.nih.gov/22245727/
6. Yan, Yongcong, Huang, Pinbo, Mao, Kai, Zhang, Jianlong, Xiao, Zhiyu. 2020. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. In Oncogene, 40, 28-45. doi:10.1038/s41388-020-01498-3. https://pubmed.ncbi.nlm.nih.gov/33051595/
智鼠故事 
